Safety of denervation following targeted lung denervation therapy for COPD: AIRFLOW-1 3-year outcomes

por Christophe, Pison, Pallav, L. Shah, Dirk-Jan, Slebos, Vincent, Ninane, Wim, Janssens, Thierry, Perez, Romain, Kessler, Gaetan, Deslee, Justin, L. Garner, Jorine, E. Hartman, Bruno, Degano, Anna, Mayr, Martin, Mayse, Alexander, D. Peterson, Arschang, Valipour
Publicado 2021